The overall goals of the Neuropathology Core (NPC) of the MADRC are to provide investigators and family members with accurate and detailed neuropathologic assessment of tissues from patients of interest to the MADRC, to provide investigators with well characterized fixed and frozen brain tissue from patients who have been clinically characterized in the Clinical Core of the MADRC and other clinics of the University of Michigan Medical Center, to facilitate research by providing tissue processing for evaluation of experimental tissues; and to provide educational resources for investigators and health care providers. To achieve these goals, the present scope of the NPC has been expanded with the recruitment of a new Director and other personnel. Dedicated space for a neuropathologic diagnostic laboratory has been identified and equipped to make it operational. The new Director will add neuropathologic expertise to the management of the NPC. Under his leadership the routine diagnostic procedures of the NPC will be expanded to involve morphometric and immunocytochemical techniques, including access to a modern morphometry facility with both light and ultrastructural capabilities. Other new initiatives will be introduced, such as brain banking of wet and frozen tissue from prior related disorders; collection of spinal cords; measures to improve the collection of high quality normal control material; introduction of more detailed clinicopathologic correlations; and easy employment of ultrastructural and morphometric techniques. Hence the NPC will expand its responsibilities and capabilities and will provide a broad basis for high quality diagnostic services with respect to dementing and degenerative disorders. These new initiatives will also provide opportunities for several collaborative arrangements with both clinical and basic scientists. The brain bank facility will continue to serve an important role as a depository of frozen and wet tissue that is provided to investigators within and outside the MADRC.
| Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384 |
| Michaud, Tzeyu L; High, Robin; Charlton, Mary E et al. (2017) Dependence Stage and Pharmacoeconomic Outcomes in Patients With Alzheimer Disease. Alzheimer Dis Assoc Disord 31:209-217 |
| Monin, Joan K; Poulin, Michael J; Brown, Stephanie L et al. (2017) Spouses' daily feelings of appreciation and self-reported well-being. Health Psychol 36:1135-1139 |
| Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738 |
| Mez, Jesse; Mukherjee, Shubhabrata; Thornton, Timothy et al. (2016) The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable. Neurobiol Aging 41:115-121 |
| Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-200.e20 |
| Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-150 |
| Jun, G; Ibrahim-Verbaas, C A; Vronskaya, M et al. (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108-17 |
| Hohman, Timothy J; Cooke-Bailey, Jessica N; Reitz, Christiane et al. (2016) Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. Alzheimers Dement 12:233-43 |
| Mossine, Andrew V; Brooks, Allen F; Jackson, Isaac M et al. (2016) Synthesis of Diverse (11)C-Labeled PET Radiotracers via Direct Incorporation of [(11)C]CO2. Bioconjug Chem 27:1382-9 |
Showing the most recent 10 out of 274 publications
